Industry News (Drug Resistance)

Hyperthermia Treatment Evaluated

Published in Hepatitis Weekly, February 8th, 1999

First Circle Medical, Minneapolis, Minnesota, announced that its advanced clinical trials are underway at the Doctor's Hospital in New Boston, Texas, on a treatment which it believes will reduce HIV in persons with multiple-drug-resistant AIDS.

These Phase II trials evaluate the effectiveness against HIV of First Circle Medical's extracorporeal whole body hyperthermia (EWBH) treatment.

EWBH is a method of elevating a person's core body temperature. First Circle Medical believes its EWBH system may offer treatment for infectious diseases, such as AIDS and hepatitis C, and certain types of cancer.

The trials evaluate 40 people...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Hepatitis Weekly

Source: Hepatitis Weekly (1999-02-08)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry